Th17 Cell-Related Gene Biomarkers in Osteoporosis: Comprehensive Bioinformatics Analysis and In Vivo Validation

 

 Buy Article Permissions and Reprints

Abstract

The interaction between the bone and immune systems has a major role in osteoporosis regulation. However, the infiltration of T helper 17 (Th17) cells and their associated genes in osteoporosis remains unclear. The GSE35959 dataset was obtained from the Gene Expression Omnibus (GEO) database, and the Immune Cell Abundance Identifier (ImmuCellAI) program was used to evaluate the abundance of 24 immune cell types, including Th17 cells. Differential analysis and relevance analysis were performed to identify differentially expressed Th17 cell-related genes (DETh17RGs) in osteoporosis. The potential functions of DETh17RGs were analyzed using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways enrichment. Hub DETh17RGs were obtained through comprehensive analysis using Weighted Gene Co-Expression Network Analysis (WGCNA) and the CytoHubba plug-in algorithm. The expression levels of hub genes were validated using additional osteoporosis datasets. Additionally, the transcript levels of Hub genes in a mice model of osteoporosis were examined using quantitative PCR (qPCR). 464 DETh17RGs were identified in this study, with 421 genes showing positive associations and 43 genes showing negative associations. Among these, seven genes (CD44, TGFB1, ACTN4, ARHGDIA, ESR1, TLN1, FLNA) were considered as Hub DETh17RGs. The qPCR transcript levels of hub DETh17RGs in a mice model of osteoporosis exhibited consistent expression trends with the bioinformatics analysis. This research enhances our understanding of the molecular mechanisms involving Th17 cells in the development of osteoporosis and contributes to the discovery of potential biomarkers.

Publication History

Received: 22 July 2023

Accepted after revision: 17 October 2023

Article published online:
17 November 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

• References

• 1 Lane JM, Russell L, Khan SN. Osteoporosis. Clin Orthop Relat Res 2000; 372: 139-150
  CrossrefPubMedGoogle Scholar
• 2 Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 2006; 17: 1726-1733
  CrossrefPubMedGoogle Scholar
• 3 Srivastava RK, Dar HY, Mishra PK. Immunoporosis: immunology of osteoporosis-role of T cells. Front Immunol 2018; 9: 657
  CrossrefPubMedGoogle Scholar
• 4 Saxena Y, Routh S, Mukhopadhaya A. Immunoporosis: role of innate immune cells in osteoporosis. Front Immunol 2021; 12: 687037
  CrossrefPubMedGoogle Scholar
• 5 Bhadricha H, Patel V, Singh AK. et al. Increased frequency of Th17 cells and IL-17 levels are associated with low bone mineral density in postmenopausal women. Sci Rep 2021; 11: 16155
  CrossrefPubMedGoogle Scholar
• 6 Huang F, Wong P, Li J. et al. Osteoimmunology: the correlation between osteoclasts and the Th17/Treg balance in osteoporosis. J Cell Mol Med 2022; 26: 3591-3597
  CrossrefPubMedGoogle Scholar
• 7 Hu Y, Han J, Ding S. et al. Identification of ferroptosis-associated biomarkers for the potential diagnosis and treatment of postmenopausal osteoporosis. Front Endocrinol (Lausanne) 2022; 13: 986384
  CrossrefPubMedGoogle Scholar
• 8 Miao YR, Zhang Q, Lei Q. et al. ImmuCellAI: a unique method for comprehensive T-cell subsets abundance prediction and its application in cancer immunotherapy. Adv Sci (Weinh) 2020; 7: 1902880
  CrossrefPubMedGoogle Scholar
• 9 Ritchie ME, Phipson B, Wu D. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 2015; 43: e47
  CrossrefPubMedGoogle Scholar
• 10 Jee WS, Yao W. Overview: animal models of osteopenia and osteoporosis. J Musculoskelet Neuronal Interact 2001; 1: 193-207
  PubMedGoogle Scholar
• 11 Jiang Y, Luo W, Wang B. et al. Resveratrol promotes osteogenesis via activating SIRT1/FoxO1 pathway in osteoporosis mice. Life Sci 2020; 246: 117422
  CrossrefPubMedGoogle Scholar
• 12 Khandelwal S, Lane NE. Osteoporosis: review of etiology, mechanisms, and approach to management in the aging population. Endocrinol Metab Clin North Am 2023; 52: 259-275
  CrossrefPubMedGoogle Scholar
• 13 Chellaiah MA, Kizer N, Biswas R. et al. Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression. Mol Biol Cell 2003; 14: 173-189
  CrossrefPubMedGoogle Scholar
• 14 Singh A, Gill G, Kaur H. et al. Role of osteopontin in bone remodeling and orthodontic tooth movement: a review. Prog Orthod 2018; 19: 18
  CrossrefPubMedGoogle Scholar
• 15 Wang YW, Lin WY, Wu FJ. et al. Unveiling the transcriptomic landscape and the potential antagonist feedback mechanisms of TGF-β superfamily signaling module in bone and osteoporosis. Cell Commun Signal 2022; 20: 190
  CrossrefPubMedGoogle Scholar
• 16 Janssens K, ten Dijke P, Janssens S. et al. Transforming growth factor-beta1 to the bone. Endocr Rev 2005; 26: 743-774
  CrossrefPubMedGoogle Scholar
• 17 Honda K, Yamada T, Endo R. et al. Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion. J Cell Biol 1998; 140: 1383-1393
  CrossrefPubMedGoogle Scholar
• 18 Gupta IR, Baldwin C, Auguste D. et al. ARHGDIA: a novel gene implicated in nephrotic syndrome. J Med Genet 2013; 50: 330-338
  CrossrefPubMedGoogle Scholar
• 19 Goel A, Chhabra R, Ahmad S. et al. DAMTC regulates cytoskeletal reorganization and cell motility in human lung adenocarcinoma cell line: an integrated proteomics and transcriptomics approach. Cell Death Dis 2012; 3: e402
  CrossrefPubMedGoogle Scholar
• 20 Krela-Kaźmierczak I, Skrzypczak-Zielińska M, Kaczmarek-Ryś M. et al. ESR1 gene variants are predictive of osteoporosis in female patients with Crohn’s disease. J Clin Med 2019; 8: 1306
  CrossrefPubMedGoogle Scholar
• 21 Zou W, Izawa T, Zhu T. et al. Talin1 and Rap1 are critical for osteoclast function. Mol Cell Biol 2013; 33: 830-844
  CrossrefPubMedGoogle Scholar
• 22 Lian G, Kanaujia S, Wong T. et al. FilaminA and Formin2 regulate skeletal, muscular, and intestinal formation through mesenchymal progenitor proliferation. PLoS One 2017; 12: e0189285
  CrossrefPubMedGoogle Scholar
• 23 Lian G, Lu J, Hu J. et al. Filamin a regulates neural progenitor proliferation and cortical size through Wee1-dependent Cdk1 phosphorylation. J Neurosci 2012; 32: 7672-7684
  CrossrefPubMedGoogle Scholar
• 24 Wang Z, Zhang X, Cheng X. et al. Inflammation produced by senescent osteocytes mediates age-related bone loss. Front Immunol 2023; 14: 1114006
  CrossrefPubMedGoogle Scholar
• 25 Bao K, Jiao Y, Xing L. et al. The role of wnt signaling in diabetes-induced osteoporosis. Diabetol Metab Syndr 2023; 15: 84
  CrossrefPubMedGoogle Scholar
• 26 Suryawanshi A, Manoharan I, Hong Y. et al. Canonical wnt signaling in dendritic cells regulates Th1/Th17 responses and suppresses autoimmune neuroinflammation. J Immunol 2015; 194: 3295-3304
  CrossrefPubMedGoogle Scholar
• 27 Li Y, Wang X, Pan C. et al. Myoblast-derived exosomal Prrx2 attenuates osteoporosis via transcriptional regulation of lncRNA-MIR22HG to activate Hippo pathway. Mol Med 2023; 29: 54
  CrossrefPubMedGoogle Scholar
• 28 Xie W, Xiao W, Tang K. et al. Yes-associated protein 1: role and treatment prospects in orthopedic degenerative diseases. Front Cell Dev Biol 2020; 8: 573455
  CrossrefPubMedGoogle Scholar